| Autor: |
Belhocine, T. Z., Tait, J. F., Vanderheyden, J.-L., Li, C., Blankenberg, F. G. |
| Zdroj: |
Journal of Proteome Research; June 2004, Vol. 3 Issue: 3 p345-349, 5p |
| Abstrakt: |
In the past decade, genomics and proteomics have begun to develop many new targets for potential diagnostic and therapeutic agents. Among the life sciences, nuclear medicine is also deeply involved in the field of clinical investigation. Experience with radiolabeled annexin V highlights the many steps required to translate a good basic-science concept into the clinical setting. This model also emphasizes the value of synergy between basic and medical specialties in developing and optimizing a clinically useful product initially derived from basic investigation. Keywords: annexin V • recombinant human • radiolabeling • apoptosis |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
